Clinical Trials Browser

Phase 1/2 × INDUSTRY × OKN 007 × Clear all

NCT03649464 2022-10-07

Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants

Phase 1/2 Withdrawn

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma